Please provide your email address to receive an email when new articles are posted on . Hydroxychloroquine was not more effective than placebo for relieving moderate-to-severe hand pain and ...
Hydroxychloroquine (Plaquenil®), especially at the higher standard dose of 400 mg per day, independently decreases the risk of cardiovascular morbidity in people with rheumatoid arthritis, according ...
Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
Hydroxychloroquine was not effective for inflammatory erosive osteoarthritis (OA) of the hands, a multicenter randomized study confirmed. At week 52, pain scores on the Australian Canadian Hand ...
Arutz Sheva spoke with Dr. Vladimir Zelenko, the Jewish doctor who recently announced his decision to close his clinic in Kiryas Joel, who came to national prominence earlier this year for treating ...
The anti-malaria drug hydroxychloroquine has shown promise in previous studies that it could potentially cure COVID-19. It is now being used for trials in hospitals all over the world and has become ...
The ORCHID trial was halted in June 2020 after a data and safety monitoring board determined that hydroxychloroquine was unlikely to benefit hospitalized patients. A National Institutes of Health-led ...
The new report entitled Hydroxychloroquine Market by Dosage Type (200 mg, 400 mg, 800 mg), Application, Distribution Channel, and Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, ...
The Pharmacy and Poisons Board has prohibited all pharmacies and chemists in the country from dispensing chloroquine and hydroxychloroquine to clients without a valid prescription from a medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results